Pharmaceuticals and Life Sciences

In the Middle East, the demand for pharmaceutical products and medical equipment is expanding rapidly, driven by the health and ageing of the nation, population growth, funding for world-class healthcare provision and the roll-out of mandatory health insurance. Still heavily dependant on imported products from Europe and the United States, the region is investing heavily in modernising the supply chain and expanding local manufacturing capability. In response to the rising demand for quality tertiary care, manufacturers are also beginning to establish R&D activity in the region.

PricewaterhouseCoopers is working with some of the major players in manufacturing, retailing and distribution, and on biotechnology initiatives.

Our consulting team, which includes biomedical engineers and pharmacists, provides advisory services including: strategy development, financial feasibility studies, regulatory considerations, strategic sourcing and supply chain optimisation, and general operational improvement.